Emerging leader in newborn care selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Framingham, MA, January 11, 2007 – clinivation, Inc. announced today that Natus Medical, Inc. (NASDAQ: BABY) has selected clinivation WorldView™ Online Regulatory Intelligence solution.
“We are pleased that Natus has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions, “All of Natus’ regulatory questions will be quickly answered with comprehensive, authoritative, and current resources and contacts,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global™ enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Natus Medical, Inc.
Natus Medical, Inc. is a medical technology company focused on developing, manufacturing and marketing products for the detection, treatment, monitoring and tracking of common disorders in newborns.
